Allarity Therapeutics, Inc.

Develops personalized cancer drugs using a diagnostic platform to predict patient response.

ALLR | NDAQ

Overview

Corporate Details

ISIN(s):: US0167445008
LEI:
Country:: United States of America
Address:: 24 SCHOOL ST., 2ND FLOOR, 2108 BOSTON
Website:: https://allarity.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company focused on developing personalized cancer treatments. The company leverages its proprietary Drug Response Predictor (DRP®) technology, a diagnostic platform that analyzes tumor biology to predict a patient's response to specific therapies. This approach aims to refine patient selection and improve clinical outcomes for its pipeline of in-licensed oncology therapeutics. Allarity's lead clinical program is stenoparib, an orally available, dual-action small molecule inhibitor being advanced for patients with advanced recurrent ovarian cancer. The company's mission is to enhance patient outcomes through data-driven decision-making and personalized cancer care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Allarity Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Allarity Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Allarity Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cantourage Group SE A European platform producing and distributing medical cannabis products to pharmacies.	Germany	HIGH
CAPRICOR THERAPEUTICS, INC. Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.	United States of America	CAPR
CAREGEN CO.,LTD. Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.	South Korea	214370
Caribou Biosciences, Inc. Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.	United States of America	CRBU
Carisma Therapeutics Inc. Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.	United States of America	CARM
Cartesian Therapeutics, Inc. Pioneering mRNA-engineered cell therapies to treat autoimmune diseases.	United States of America	RNAC
CASI Pharmaceuticals, Inc. Develops and commercializes drugs for oncology, transplant, and autoimmune disease.	United States of America	CASI
CASSAVA SCIENCES INC Clinical-stage biotech developing oral drug simufilam for CNS disorders like TSC-related epilepsy.	United States of America	SAVA
CATALYST PHARMACEUTICALS, INC. Advancing therapies for rare neuromuscular and neurological diseases like LEMS.	United States of America	CPRX
cbdMD, Inc. Produces & distributes lab-tested CBD wellness products for people and pets.	United States of America	YCBD